Member Info for Pinkers

John Lee pointed out that CNC should benefit from increased US spending in the defence sector. In the same column he tipped Quarto and that hasn't moved at all. Lee is extremely well connected, on the inside track. Holding a small number of small-caps he has been pushing in the FT for years, both have featured many times. In the long run, he usually gets it right. And when he doesn't, he never mentions the stock again: Christies support is a good example. I checked it out after he tipped it and was put off by its weak balance sheet; the stock has since lost half of its value.

Mr Lee has been banging on about CNC for years. I do not believe that his most recent coverage is solely responsible for this phenomenal rise in the last few days. However, as Mr Lee has pointed out for the first time, the Trump effect may well play a role.

Total equity currently stands at MINUS 6.73m; i.e. liabilities are greater than assets. Current liabilities also outstrip current assets. This does not install confidence. Debt needs to be reduced significantly before an investment case can be made.

In complete agreement. Edelman, no matter how dodgy a character, clearly has made a huge contribution in forcing the company to remodel and clean up! In fact, Blinkx appears to be well on the way to become a significant niche player and market leader in its field. However, hold your horses… as far as the s/p is concerned, it will take at least another 12 months to recover to levels above 50p; provided, of course, things remain on track and the company can produce a genuine profit within the next six months.

The RNS is well communicated, quietly confident and well delivered.. Encouraging.

I phoned Bioquell investor relations. A joke. They could not even reassure me whether or not the TRaC disposal is still on track! Not to mention a timeline. Well, this morning I sold my entire holding; don't like the smell of this one… tidy profit… and a Rothschild said: "Sell too soon!".

Worrying. Tosca and Griffiths now holding 35%; add other major institutional shareholders and we are looking at well over 60%. Us small fry might well have to succumb to a low-ball grab well below 50p.

So much for Google Finance… CNC down by a whopping 45%!

The Chinese will not and should not get away with this opportunistic bid. Quinn will turn BBY around. £3 is a NO-GO! £4 nearer the mark - watch this space! Further to this: http://pinkerspost.com/?p=312

Blooming Bloomsbury! Read all on http://pinkerspost.com/?p=723

Mr Woodford has been an investor in Vernalis for many years, long before he launched his own independent vehicle. He's quite brilliant. Vernalis has a long way to go. This stock will at least double over the next 12 months. Despite the elevated levels, there are still quite few bargains out there… Woodford is a contrarian stock picker and that's why he tends to be ahead of the curve. Further to this: http://pinkerspost.com/?p=702

Anglo American angel cake: Have it & eat it! Takeover before long! http://pinkerspost.com/?p=690

Fenner is a winner! Buy the blood! http://pinkerspost.com/?p=645 

John Menzies is a winner! Buy the blood! http://pinkerspost.com/?p=645 

Connect is a winner: Buy the blood! http://pinkerspost.com/?p=645 

Well, encouraging news no doubt. However, what a wise man Leo Quinn is: Clearly under no illusion that this will be his challenge of a lifetime! One can only hope that Mr Marshall and his colleagues on the board will give the 'carte blanche' he surely is entitled to! After all, naughty Balfour Beatty has broken the golden rule: The conceived wisdom is that profit warnings come in three. Well, Balfour has just delivered its fifth in less than two years and is in danger of losing its last smidgen of credibility. Chairman Steve Marshall is on his way out: Thank God for that. Hope for Marshall Plan B? Further reading: http://pinkerspost.com/?p=466

The only surprise is that this has taken so long. As previously stated, Bioquell's recent trading update was completely misinterpreted: This was by no means a profit warning but honest and open guidance, bearing the sign of prudent management and a well-managed company, setting a good example other publicly listed companies should follow. However, even after the significant surge in the company's s/p over the last couple of days, it remains lowly rated and vulnerable to a bid. Bioquell may be a 'tiddler' but it is a world leader in its field and a valuation of around 200p would be about right. Other small companies currently trading at depressed levels for not other reason than being 'below radar' are Ubisense and Vernalis (both AIM listed); again, tiny by market cap but world-leaders in their field. http://pinkerspost.com

The good news: No accounting issues. Provided management can be trusted… The bad news: All the rest. The Qatar Investment Authority which owns 26% of the company through their subsidiary Qatar Holding, will not be amused. The "detailed strategic update" alongside November's half-year figures that spooked the markets should, however, be interpreted as good, not bad news. Major surgery is required to save the patient and a 50% divi cut would be a good start. The 'big four' face extinction unless they face up to reality: Adapt or die. Supermarkets not so super, anymore? Further to this: http://pinkerspost.com/?p=451

Naughty Balfour Beatty has broken the golden rule: The conceived wisdom is that profit warnings come in three. Well, Balfour has just delivered its fifth in less than two years and is in danger of losing its last smidgen of credibility. Chairman Steve Marshall is on his way out: Thank God for that. Hope for Marshall Plan B? Further reading: http://pinkerspost.com/?p=466

A very good price for PB. Balfour shareholders should be delighted. However, the company remains up for grabs: Balfour Beatty is now a one of the most "obvious" targets in the construction & support industry. Indeed, the whole sector is ripe for consolidation. Just look at the Times equity prices columns and one cannot help but notice the sheer length of the two listings (Construction & Property and Professional & Support Services). Combined, and the cross-overs are only too evident, this would be the longest column in the paper, easily exceeding Natural Resources. More on this subject: http://pinkerspost.com/?p=312